A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease.
To examine the efficacy of EPA’s label in conveying toxicity information to potential consumers, the researchers conduct an incentivized field experiment with eye tracking to evaluate the ...
NEW YORK, Feb. 23 (UPI) --A new study that compares the label accuracy of a generic drug versus a dietary supplement with the same active pharmaceutical ingredient found that the supplement fared very ...
A comprehensive national study examining dementia patient outcomes for Medicare Advantage beneficiaries with Alzheimer’s disease and related dementias (ADRD) uncovered key insights into healthcare ...
UNESCO warned that the “low prevalence of fact-checking highlights influencers’ vulnerability to misinformation, which can have far-reaching consequences for public trust and discourse.” According to ...
A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results